Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1 Sarcoma 1 Breast 1

Conditions

Vomiting 1 Neoplasms 1 Breast Neoplasms 1

Interventions

Paclitaxel 26 pembrolizumab 24 Docetaxel 20 Capecitabine 19 Fulvestrant 17 Trastuzumab 16 Anastrozole 15 Cyclophosphamide 14 Lapatinib 13 Letrozole 11 Carboplatin 11 Radiotherapy 10 Doxorubicin 10 palbociclib 9 Therapeutics 9 Nivolumab 9 Exercise 9 Gemcitabine 8 Cisplatin 8 Blood Specimen Collection 8 Tamoxifen 7 Bevacizumab 7 liposomal doxorubicin 6 exemestane 6 abemaciclib 6 Vinorelbine 6 Standard of Care 6 Fluorouracil 6 atezolizumab 5 Surveys and Questionnaires 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Pantoprazole × Breast × Clear all

NCT03948477 2022-05-25

PantoCIN

University of Auckland, New Zealand

Phase 2 Completed

Breast Neoplasms, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡